|
Delayed
Nasdaq Stockholm
07:59:31 2026-10-30 EDT
|
5-day change | 1st Jan Change | ||
| 0.3545 SEK | -5.59% |
|
-16.29% | -57.24% |
| 10-21 | Alzinova Finalizes US Trial Sites for Mid-stage Alzheimer's Disease Vaccine Study | MT |
| 10-21 | Alzinova selects seven U.S. trial sites ahead of phase IIa study | FW |
Projected Income Statement: Alzinova AB
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | - | - | 0.27 | - | - | 31.35 | - | 9.25 |
| Change | - | - | - | - | - | - | - | - |
| EBITDA 1 | -7.519 | - | - | -20.38 | -25.6 | -1.95 | -106 | -106 |
| Change | - | - | - | - | -25.61% | 92.38% | -5,335.9% | 0% |
| EBIT 1 | -7.519 | - | -16.52 | -20.38 | -25.6 | -1.95 | -106 | -106 |
| Change | - | - | - | -23.36% | -25.61% | 92.38% | -5,335.9% | 0% |
| Interest Paid | - | - | - | - | - | - | - | - |
| Earnings before Tax (EBT) 1 | -7.552 | -13.09 | -16.48 | -20.55 | -26.27 | -1.2 | -64.85 | -51.95 |
| Change | - | -73.3% | -25.92% | -24.71% | -27.8% | 95.43% | -5,304.17% | 19.89% |
| Net income 1 | -7.552 | -13.09 | -16.48 | -20.55 | -26.27 | 1.55 | -84 | -84 |
| Change | - | -73.3% | -25.92% | -24.71% | -27.8% | 105.9% | -5,519.35% | 0% |
| Announcement Date | 2/24/22 | 2/23/23 | 2/28/24 | 2/27/25 | 3/25/26 | - | - | - |
1SEK in Million
Estimates
Forecast Balance Sheet: Alzinova AB
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | -28 | - | -22 | -15.5 | 15.5 | -9 | -4 | - |
| Change | - | - | - | 29.55% | 200% | -158.08% | 55.56% | - |
| Announcement Date | 2/24/22 | 2/23/23 | 2/28/24 | 2/27/25 | 3/25/26 | - | - | - |
1SEK in Million
Estimates
Cash Flow Forecast: Alzinova AB
| Fiscal Period: December | 2021 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
| CAPEX 1 | - | - | 16.78 | 26.55 | 25 | 30 | 30 |
| Change | - | - | - | 58.23% | -5.85% | 20% | 0% |
| Free Cash Flow (FCF) 1 | -27.14 | -34.82 | -37.05 | -39.58 | -72 | -114 | -114 |
| Change | - | - | -6.4% | -6.85% | -81.9% | -58.33% | 0% |
| Announcement Date | 2/24/22 | 2/28/24 | 2/27/25 | 3/25/26 | - | - | - |
1SEK in Million
Estimates
Forecast Financial Ratios: Alzinova AB
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||
| EBITDA Margin (%) | - | - | - | - | - | -6.22% | - | -1,145.95% |
| EBIT Margin (%) | - | - | -6,119.26% | - | - | -6.22% | - | -1,145.95% |
| EBT Margin (%) | - | - | -6,103.7% | - | - | -3.83% | - | -561.62% |
| Net margin (%) | - | - | -6,103.7% | - | - | 4.94% | - | -908.11% |
| FCF margin (%) | - | - | -12,895.19% | - | - | -229.67% | - | -1,232.43% |
| FCF / Net Income (%) | 359.39% | - | 211.27% | 180.25% | 150.7% | -4,645.16% | 135.71% | 135.71% |
Profitability | ||||||||
| ROA | - | - | - | - | - | - | - | - |
| ROE | - | - | -15.02% | -17.29% | -21.37% | -19.6% | -45% | -39.3% |
Financial Health | ||||||||
| Leverage (Debt/EBITDA) | - | - | - | - | -0.61x | - | - | - |
| Debt / Free cash flow | - | - | - | - | -0.39x | - | - | - |
Capital Intensity | ||||||||
| CAPEX / Current Assets (%) | - | - | - | - | - | 79.74% | - | 324.32% |
| CAPEX / EBITDA (%) | - | - | - | -82.34% | -103.71% | -1,282.05% | -28.3% | -28.3% |
| CAPEX / FCF (%) | - | - | - | -45.3% | -67.08% | -34.72% | -26.32% | -26.32% |
Items per share | ||||||||
| Cash flow per share 1 | - | - | - | - | - | - | - | - |
| Change | - | - | - | - | - | - | - | - |
| Dividend per Share 1 | - | - | - | - | - | - | - | - |
| Change | - | - | - | - | - | - | - | - |
| Book Value Per Share 1 | - | - | - | - | 1.169 | 0.57 | 0.65 | 0.74 |
| Change | - | - | - | - | - | -51.24% | 14.04% | 13.85% |
| EPS 1 | -0.48 | - | -0.41 | -0.31 | -0.27 | -0.14 | -0.27 | -0.27 |
| Change | - | - | - | 24.39% | 12.9% | 48.15% | -92.86% | 0% |
| Nbr of stocks (in thousands) | 15,776 | - | 44,531 | 89,165 | 104,324 | 316,059 | 316,059 | 316,059 |
| Announcement Date | 2/24/22 | - | 2/28/24 | 2/27/25 | 3/25/26 | - | - | - |
1SEK
Estimates
| 2026 * | 2027 * | |
|---|---|---|
| P/E | -2.68x | -1.39x |
| PBR | 0.66x | 0.58x |
| EV / Sales | 3.5x | - |
| Yield | - | - |
EPS & Dividend
Y-o-Y evolution of P/E
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ALZ Stock
- Financials Alzinova AB
Select your edition
All financial news and data tailored to specific country editions
